AZP2006, a new promising treatment for Alzheimer’s and related diseases
Abstract Progranulin (PGRN) is a protein with multiple functions including the regulation of neuroinflammation, neuronal survival, neurite and synapsis growth. Although the mechanisms of action of PGRN are currently unknown, its potential therapeutic application in treating neurodegenerative disease...
Guardado en:
Autores principales: | N. Callizot, C. Estrella, S. Burlet, A. Henriques, C. Brantis, M. Barrier, M. L. Campanari, P. Verwaerde |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af022f0472c645e296c8b3fa2b7476bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Hannah Walgrave, et al.
Publicado: (2021) -
Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross C, et al.
Publicado: (2018) -
Silver-coated gold nanorods as a promising antimicrobial agent in the treatment of cancer-related infections
por: Zhang J, et al.
Publicado: (2018) -
Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation
por: Hui Wang, et al.
Publicado: (2021) -
Which new approaches to tackling neglected tropical diseases show promise?
por: Jerry M Spiegel, et al.
Publicado: (2010)